Skip to content

Using Laser Spatiotemporal Photoplethysmogram and Computational Method for Management of Chronic Disorders.

Laser Spatiotemporal Photoplethysmogram and Computational Method for Extended Chronic Cardiometabolic Therapeutic Care

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06717646
Acronym
LSPPG
Enrollment
200
Registered
2024-12-05
Start date
2024-04-11
Completion date
2025-06-30
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose Monitoring, Blood Pressure Measurement

Brief summary

This investigational study is carried out to find out if a smartwatch monitor worn on the wrist that acts like a blood pressure monitor, will be able to replace the traditional blood pressure measurements using the traditional cuff that is wrapped around your arm.

Detailed description

NHC inpatients (Group A) Patients will be required to put on the LSPPG wearable sensor to take measurement once a day, starting from the day of recruitment till day of discharge. 3 ECG electrodes with cable linking to the LSPPG sensor wearable will also be attached on the chest. This helps to capture ECG rhythm at the same time. Study team member will assist the patient to take daily measurement. NHC Outpatients scheduled for 24-Hour ABP monitoring (Group B) Patients will wear the LSPPG wearable sensor whilst wearing the 24-hour ambulatory blood pressure monitor. 3 ECG electrodes with cable linking to the LSPPG sensor wearable will also be attached on the chest. This helps to capture ECG rhythm at the same time. Readings will be obtained on an hourly basis during the duration of wearing the ambulatory blood pressure machine (clinical grade device).

Interventions

None listed

Sponsors

National Medical Research Council (NMRC), Singapore
CollaboratorOTHER_GOV
National Heart Centre Singapore
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Above 21 years of age * Sufficient language skills in English, Chinese, Malay or Tamil * Provided informed consent

Exclusion criteria

* Skin sensitivity to adhesives

Design outcomes

Primary

MeasureTime frameDescription
Comparable results to traditional methods24 HoursPerform comparably to the 24-hour ambulatory blood pressure meters and continuous glucose monitors (CGM) to establish hypertension and blood glucose changes
Improve efficiency24 HoursProvide real time feedback to patients and healthcare providers to individualize hypertension / hyperglycemic treatment
Lifestyle Improvement24 HoursConsider patient lifestyle changes and reduce medication burden, especially in the elderly when blood pressure control is optimal.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026